Submit Deal

BRANDON CAPITAL

HQ - Melbourne

Summary

Brandon Capital Partners is a fund management business focused on investments in life science ventures.

Deals Overview

Total Deals6

Valued Deals5

Total Value£ 364 M

Avg. Deal Size£ 73 M

Market Context

Senior Management

Jonathan Tobin
Partner

Sort

22 Nov 2022|Germany|Biotechnology

Target: CATALYM

Bidder: BRANDON CAPITAL

7 Service Providers

3 Target | 4 Bidder

9 Dealmakers

5 Target | 4 Bidder

£ 43 M

Value

18 Apr 2024|United Kingdom|Pharmaceuticals

Target: PATHIOS THERAPEUTICS

Bidder: BRISTOL MYERS SQUIBB COMPANY

5 Service Providers

2 Target | 3 Bidder

6 Dealmakers

3 Target | 3 Bidder

£ 20 M

Value

21 May 2024|United States|Pharmaceuticals

Target: PHEON THERAPEUTICS

Bidder: TCGX

3 Service Providers

1 Target | 2 Bidder

2 Dealmakers

1 Target | 1 Bidder

£ 94 M

Value

16 Jul 2024|Germany|Biotechnology

Target: CATALYM

Bidder: OMEGA FUNDS

4 Service Providers

2 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 115 M

Value

08 Jul 2024|United Kingdom|Biotechnology

Target: MYRICX BIO

Bidder: NOVO HOLDINGS A/S

7 Service Providers

2 Target | 5 Bidder

7 Dealmakers

2 Target | 5 Bidder

n/a

Value

03 Feb 2025|Australia|Biotechnology

Target: ADVANCELL

Bidder: SYMBIOSIS

4 Service Providers

1 Target | 3 Bidder

4 Dealmakers

1 Target | 3 Bidder

£ 90 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy